- Report
- August 2023
- 51 Pages
China
From €530EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
Netherlands
From €530EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
Germany
From €530EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
France
From €530EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
Brazil
From €530EUR$600USD£460GBP
- Report
- April 2025
- 150 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- March 2025
- 150 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- March 2025
- 150 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- March 2025
- 150 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- February 2025
- 150 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- December 2024
- 150 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- April 2023
- 150 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- April 2025
- 220 Pages
Global
From €1765EUR$1,997USD£1,529GBP
- Report
- October 2025
- 82 Pages
Qatar
From €4287EUR$4,850USD£3,715GBP
- Report
- October 2025
- 87 Pages
South Korea
From €4287EUR$4,850USD£3,715GBP
- Report
- June 2025
- 80 Pages
From €3050EUR$3,450USD£2,642GBP
- Report
- February 2025
- 135 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- January 2025
- 50 Pages
Global
From €2209EUR$2,499USD£1,914GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$6,047USD£4,475GBP
- Report
- December 2024
- 55 Pages
Global
From €2209EUR$2,499USD£1,914GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more